Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
02/2002
02/13/2002EP1178987A1 Substituted benzoylisoxazoles and the use thereof as herbicides
02/12/2002US6346522 1-arylpyrazoles; systemic pesticides, insecticides, larvicides, miticides, antiprotozoa, and anthelmintic agents; agriculture, horticulture, animal husbandry, public health and veterinary medicine
02/12/2002CA2053705C Piperazine derivatives
02/07/2002WO2002009703A1 Method for treating cryptorchidism
02/07/2002WO2001030333A3 Tissue factor antagonists and methods of use thereof
02/07/2002US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc.
02/07/2002US20020016365 Nonsteroidal gestagens
02/07/2002US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha
02/07/2002US20020016326 Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors
02/07/2002US20020016323 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
02/06/2002EP1177179A1 Benzohetero cyclylcyclo hexenones and their use as herbicides
02/06/2002EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists
02/06/2002CN1334807A 1-heterocycle substd. diarylamines
02/05/2002US6344587 Reacting hydroxyethyl hydrazine derivatives with sodium, potassium or ammonium thiocyanate; reacting the resulting thiosemicarbazide derivatives with formic acid, if appropriate in the presence of a catalyst
02/05/2002US6344505 Mono- and bis-benzotriazolyldihydroxybiaryl UV absorbers
02/05/2002US6344454 Contraceptive preparations,treatment of endometriosis, gynecological disorders,premenstrual symptoms, male birth control, male hrt and hormone therapy and for treating andrological disease agents.
02/05/2002CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists
02/05/2002CA2082074C 1h-substituted-1,2,4-triazole compounds for treatment of cardiovascular disorders
01/2002
01/31/2002WO2002008834A1 Radiation sensitive compositions containing image quality and profile enhancement additives
01/31/2002US20020013491 Reacting a carboxylic acid with (di or tri)aryl phosphite
01/31/2002US20020013473 Novel ruthenium metal alkylidene complexes coordinated with triazolylidene ligands that exhibit high olefin metathesis activity
01/31/2002US20020013472 Oxyranyle-triazoline thiones and their use as microbicides
01/31/2002DE10035011A1 Pure N,N'-carbonyl-diazole preparation in high yield, by reacting azolide salt with phosgene in aromatic or ether solvent
01/31/2002DE10034803A1 Substituierte Sulfonsäureanilide Substituted Sulfonsäureanilide
01/30/2002EP1175383A1 Glucocorticoid receptor modulators
01/30/2002EP1175213A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
01/30/2002CN1333759A Acrylonitrile compounds
01/30/2002CN1333754A Benzoheterocycles and their use as MEK inhibitors
01/30/2002CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
01/29/2002US6342513 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
01/24/2002WO2002006272A1 Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
01/24/2002WO2002006250A1 Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists
01/24/2002WO2002006249A1 Method for producing 1-substituted-1,2,3-triazole derivative
01/24/2002WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
01/24/2002WO2002006244A1 Heterocyclic substituted herbicidal sulphonic acid anilides
01/24/2002US20020010286 Multifunctional cyanate ester and epoxy blends
01/24/2002US20020009650 High electroconductivity
01/24/2002CA2415961A1 Production method of 1-substituted-1,2,3-triazole derivatives
01/24/2002CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
01/23/2002EP1174413A2 Process for production of carboxylic acid aryl esters
01/23/2002EP1173468A1 Integrin receptor antagonists
01/23/2002EP1173425A1 (-)-enantiomer of the 2- 2-(1- chlorocyclopropyl)-3- (2-chlorophenyl) -2- hydroxypropyl] -2,4- dihydro- 1,2,4] -triazole -3-thione
01/17/2002WO2002003912A2 Novel c-4 substituted retinoids
01/17/2002WO2000061129A3 S-hydroxynefazodone
01/17/2002US20020006947 Aryl substituted pyrazoles, triazoles, and tetrazoles, and the use thereof
01/16/2002EP1172357A1 Process for the preparation of hydrazinecarboxylic esters and intermediates of this process
01/16/2002EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors
01/16/2002EP1171133A2 R-hydroxynefazodone
01/16/2002CN1331563A Fungicide mixture
01/10/2002WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
01/10/2002WO2002002512A2 Compounds to treat alzheimer's disease
01/10/2002WO2001056993A3 Pyrazole compositions useful as inhibitors of erk
01/10/2002US20020004531 Nitrone inhibition of cancer development
01/10/2002CA2410651A1 Compounds to treat alzheimer's disease
01/09/2002EP1170290A2 Compounds having ultra-violet absorption properties
01/09/2002CN1330640A Cyclic hydrazine derivatives as TNF-alpha inhibitors
01/03/2002US20020002195 Pesticidal 1-polyarylpyrazoles
01/02/2002EP1165547A1 Substituted benzoylpyrazoles as herbicides
01/02/2002EP1165530A2 Dihetero-substituted metalloprotease inhibitors
01/02/2002EP1165512A2 Method for arylating aza-heterocycles with activated aromatic compounds in the presence of cesium carbonate
01/02/2002EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
01/01/2002CA2029105C Halogenated sulphonylaminocarbonyltriazolinones
12/2001
12/27/2001WO2001097860A2 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
12/27/2001US20010056187 Method for producing triazolinethione derivatives
12/27/2001US20010056092 Diaminocyclobutene-3,4-dione derivatives, their preparation and use
12/27/2001CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
12/26/2001CN1328466A Use of antifungal agents for treating scleroses
12/26/2001CN1327793A Pyrrolo-triazine and pyrimidine compounds
12/25/2001US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation
12/25/2001US6333343 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents
12/25/2001US6333323 Indole derivatives with antiviral activity
12/25/2001US6333296 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
12/25/2001US6333174 Transforming a bacterial inoculant with a replicable plasmid having a double stranded dna, a tryptophan promoter, ribosome binding site, a translation start signal with structural genes coding a leade, culture with tryptophan
12/20/2001WO2001096316A1 Method for preparing substituted 5-amino-n-phenyl-1,2,4-triazole-3-sulfonamides
12/20/2001WO2001096315A1 Process for the preparation of 1,2,4-triazolin-5-one derivatives
12/20/2001WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
12/20/2001WO2001044207A3 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
12/20/2001WO2001019770A3 Rxr modulators with improved pharmacologic profile
12/20/2001DE10038020A1 Pure 5-amino-N-phenyl-1,2,4-triazole-3-sulfonamide preparation in high yield for use as agrochemical intermediate, by reacting corresponding sulfonyl chloride and aniline compounds in the absence of solvents
12/20/2001CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
12/20/2001CA2411366A1 Process for the preparation of 1,2,4-triazolin-5-one derivatives
12/19/2001CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/19/2001CN1076346C Process for producing aromatic or heteroaromatic sulfur compounds
12/18/2001US6331640 Diaminopropionic acid derivatives
12/18/2001US6331542 Protease inhibitors
12/18/2001US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
12/18/2001CA2018769C Adduct-aldehyde and its use for the preparation of a vitamin-d compound
12/18/2001CA2006309C Azolylmethylcyclopentane benzylidene fungicide
12/13/2001WO2001094320A2 Process to prepare sulfonamides
12/13/2001WO2001094318A2 Method for synthesis of substituted azole libraries
12/13/2001WO2001094317A2 Method for synthesis of substituted azole libraries
12/13/2001US20010051645 Thyroid receptor ligands
12/12/2001EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors
12/12/2001CN1325848A Herbicidal 3-aryl-1,2,4-triazole derivative
12/12/2001CN1076019C Preparation of triazoles by organometallic addition to ketonts and intermediates therefor
12/11/2001US6329523 Compounds having a plurality of nitrogenous substitutents
12/11/2001US6329521 Process for preparing substituted benzoyl cyanide amidinohydrazones
12/11/2001US6329445 Ultraviolet-ray absorbing power and oxidation resistance; used for contact lens, intraocular lens and an artificial cornea
12/11/2001US6329411 Triazolyl disulphides
12/11/2001US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 178